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A B S T R A C T   
This study investigated whether a ready-to-use extract obtained using a natural deep eutectic solvent (NADES) 
affects the pharmacokinetic profile of blueberry phenolic compounds compared to organic solvent (SORG)- 
extracted compounds. SORG extract was administered as an aqueous solution after solvent removal. Wistar rats 
received a single dose of crude extract of blueberry obtained using NADES (CE-NADES) or SORG (CE-SORG), 
followed by LC-DAD-MS/MS analysis of blood and cecal feces. Non-compartmental pharmacokinetic analysis 
revealed that CE-NADES increased the bioavailability of anthocyanins by 140% compared to CE-SORG. CE- 
NADES increased the stability of phenolic compounds during in vitro digestion by delaying gastric chyme 
neutralization. These results suggest that besides being an eco-friendly solvent for the extraction of phyto-
chemicals, choline chloride:glycerol:citric acid-based NADES can be used as a ready-to-use vehicle for increasing 
oral absorption of bioactive compounds such as anthocyanins.   
1. Introduction 
Natural deep eutectic solvents (NADES) represent a new green 
strategy to overcome the toxicity and environmental disadvantages of 
conventional organic solvents, such as methanol, acetone and formic 
acid, for the extraction of plant phytochemicals (Misan et al., 2020). 
NADES are composed of a mixture of a hydrogen receptor (usually 
choline chloride, ChCl) and a natural hydrogen donor such as amino 
acids, carboxylic acids and sugars, among others (Paiva, Craveiro, 
Aroso, Martins, Reis, & Duarte, 2014) and exhibit high extraction effi-
ciency for various natural compounds (Misan et al., 2020). 
We have recently demonstrated that a choline chloride:glycerol:cit-
ric acid (0.5:2:0.5, molar ratio) NADES is as efficient as the conventional 
organic solvent for the extraction of anthocyanins from blueberries 
(Silva, Pauletto et al., 2020a). Moreover, the blueberry extract obtained 
using this NADES mixture exhibited a protective index of 94% against 
the formation of ethanol-induced gastric ulcers in rats (Silva, Rodrigues 
et al., 2020b). No solvent was removed before using the extract and no 
toxicity was observed for the NADES per se, demonstrating that this 
NADES mixture can be used to obtain ready-to-use extracts (Silva, 
Rodrigues et al., 2020b). Thus, NADES have become an attractive 
alternative to increase the nutraceutical products field, because they are 
composed of food-grade ingredients that apparently would not need to 
be removed before use (Dai et al., 2020; Panić et al., 2019; Silva, 
Rodrigues et al., 2020b). 
Blueberry is particularly rich in phenolic compounds, such as an-
thocyanins, hydroxycinnamic acid derivatives and flavonols (Zhong, 
Sandhu, Edirisinghe, & Burton-Freeman, 2017). The phenolic com-
pounds of blueberry, including anthocyanins, modulate various cellular 
processes and have been implicated in the inhibition of cancer cell 
proliferation and prevention of obesity, type 2 diabetes, inflammation 
and cardiovascular disease (Fang, 2014). 
The systemic biological activity of most phenolic compounds is 
limited by their low bioavailability, which is around 0.2% for 
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chlorogenic acids and ranges from 0.7% to 1.1% for anthocyanins and 
most hydroxycinnamic acids from blueberry (Rodriguez-Mateos et al., 
2016; Zhong et al., 2017). In general, phenolic compounds are absorbed 
throughout the gastrointestinal tract, especially in the stomach, small 
intestine and colon (Teng & Chen, 2019). The portion of phenolic 
compounds that is not absorbed up to the small intestine can be exten-
sively metabolized by the colonic microbiota into a series of simple 
phenolic acids that can reach the circulation and are likely implicated in 
many health benefits (Augusti et al., 2021). 
Interestingly, the use of NADES as a vehicle has been demonstrated 
to increase the bioavailability of rutin, calycosin-7-O-β-D-glucoside, 
puerarin isoflavones, hydroxysafflor yellow A and anhydrosafflor yellow 
B in rodents (Dai et al., 2020; Faggian et al., 2016; Huang et al., 2021; 
Tong et al., 2021). Increased phenolic solubility has been suggested to be 
responsible for this effect that resulted in peak phenolic plasma levels 
that were 2–4 times greater when NADES vehicles were used compared 
to aqueous suspensions (Dai et al., 2020; Faggian et al., 2016; Tong 
et al., 2021). However, research concerning the effect of NADES on the 
bioavailability of plant phenolics in vivo is scarce. Only compounds 
belonging to the flavonol (rutin; Faggian et al., 2016), isoflavonol 
(calycosin-7-O-β-D-glucoside; Dai et al., 2020; and puerarin isoflavones; 
Huang et al., 2021) and quinochalcone C-glycosides (hydroxysafflor 
yellow A and anhydrosafflor yellow B; Tong et al., 2021) classes have 
been investigated. The expansion of bioavailability studies to other 
classes of phenolic compounds from phytochemical-rich plant sources 
such as blueberry will boost strategies for maximizing the potential 
health benefits of these phytochemicals by means of NADES. 
We hypothesized that a food-grade NADES yields a ready-to-use 
blueberry extract exhibiting higher bioavailability of phenolic com-
pounds than organic solvent-extracted phenolics. Thus, the objective of 
this study was to investigate the bioavailability of blueberry phenolic 
compounds extracted with NADES or conventional organic solvent, 
elucidating the differences in the pharmacokinetic profile and in the 
bioaccessibility between these different extracts. 
2. Materials and methods 
2.1. Chemicals, materials and fruit samples 
Choline chloride (ChCl; 98%) and trifluoroacetic acid (TFA; 99%) 
were acquired from Sigma-Aldrich (St. Louis, MO, USA), glycerol was 
from Belga (Parana, Brazil) and citric acid was from Vetec (Rio de 
Janeiro, Brazil). Methanol, acetonitrile and formic acid (88%) were from 
J.T. Baker® (Center Valley, PA, USA). Pepsin, pancreatin and bile salts 
were acquired from Sigma-Aldrich (P7000, P7545 and C1254; St Louis, 
MO, USA). 
Liquid chromatography (LC)-grade water was obtained from a Milli- 
Q system (Millipore, Bedford, MA, USA). Polytetrafluoroethylene sy-
ringe filter membrane (PTFE) and C18 cartridges for reversed-phase 
solid phase extraction (SPE; Sep-Pak® Vac 6 cc, 500 mg/6 mL) were 
from Waters (Milford, MA, USA). Analytical standards gallic acid (98%), 
quercetin (95%), ferulic acid (99%), vanillic acid (97%) and cyanidin 3- 
glucoside (95%) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). 
Blueberry fruits (Vaccinium corymbosum) of the cultivar O’Neal were 
collected in an orchard belonging to the Brazilian Agricultural Research 
Corporation (EMBRAPA-Clima Temperado) located in Pelotas city (Rio 
Grande do Sul State) in November 2018. The fruits were lyophilized and 
ground in a mill in liquid nitrogen until obtaining a visually homoge-
neous powder; samples obtained were stored at − 20 ◦C. 
2.2. Determination of blueberry powder particle size 
The particle size of blueberry powder samples obtained after 
lyophilization and grounding was evaluated using a laser diffraction 
particle size analyzer, equipped with a sonication control unit (model LS 
13 230, Beckman Coulter, California, USA). Triplicate samples were 
added to the equipment until optimal obscuration was achieved in the 
software. Thereafter, the powders were dispersed in an aqueous medium 
and submitted to an ultrasound treatment for 1 min inside the equip-
ment before analysis. 
2.3. Preparation of NADES and blueberry extracts 
The composition of NADES was chosen based on a previous study 
that investigated the best conditions for the extraction of blueberry 
anthocyanins (Silva, Pauletto et al., 2020a). NADES was prepared by 
mixing choline chloride, glycerol, and citric acid at a molar ratio of 
0.5:2:0.5, plus 25% water according to Silva, Pauletto et al. (2020a). 
This NADES was previously characterized by our research group (Silva, 
Pauletto et al., 2020a) using Fourier-transformed infrared spectroscopy 
(FRI) and differential scanning calorimetry (DSC) analysis, which 
showed changes in the characteristic bands of the initial reagents and 
the presence of hydrogen bonds confirming the formation of deep 
eutectic properties after the preparation of this NADES mixture. 
To obtain the crude extract using NADES (CE-NADES), 8 g of 
powdered blueberry samples (average particle size: 715.5 ± 12.3 μm) 
was extracted with 40 mL (8:40, w/v) of NADES, as previously described 
by Silva, Pauletto et al. (2020a). After solvent addition, samples were 
submitted to an ultrasonic bath (40 kHz, 50 min at room temperature) 
and then centrifuged at 2100 × g for 15 min. Sample temperature did not 
exceed 33 ◦C during this ultrasound-assisted extraction, which along 
with the low pH of the extraction solvent contributed to preserve 
phenolic compounds during extraction. To obtain enough extract for the 
whole animal experiment, this extractive procedure was repeated until 
approximately 1.5 L of crude blueberry extract was obtained, with a 
total of 0.3 kg of blueberry powder used. The supernatants were 
collected, combined and adjusted with a small volume of NADES to 
result in a solution containing exactly 1.10 mg of total phenolic com-
pounds/mL of CE-NADES. 
The crude extract obtained using organic solvent (CE-SORG) was 
extracted according to Pertuzatti et al. (2016) with the following mod-
ifications. Blueberry powder (8 g; average particle size: 715.5 ± 12.3 
μm) was mixed with 20 mL of a methanol:water:formic acid mixture 
(50:48.5:1.5; v/v/v). Thereafter, the sample was subjected to an ultra-
sonic bath (40 kHz, 2 min) and centrifuged for 10 min at 1200×g. The 
supernatant was separated, whereas the residue was re-extracted once. 
The supernatants obtained were combined, totaling approximately 40 
mL (8:40, w/v). This extraction procedure has been demonstrated to 
recover 99% of anthocyanins and 98% of non-anthocyanin compounds 
from blueberries (Pertuzatti et al., 2016; Pertuzatti, Barcia, Gómez- 
Alonso, Godoy, & Hermosín-Gutiérrez, 2021). In addition, this extrac-
tive procedure with organic solvent yielded nearly 99% of the phenolic 
amount obtained in the NADES extraction. The extractive procedure 
using organic solvent was repeated to extract up to 0.3 kg of blueberry 
powder yielding approximately 1.5 L of crude blueberry extract. Sol-
vents were evaporated using a rotary evaporator (Bûchi-R3TM, Flawil, 
Switzerland) at 38 ± 2 ◦C and the dry content was dissolved in 
approximately 1.5 L of distilled water to result in a solution containing 
exactly 1.10 mg of total phenolic compounds/mL of CE-SORG. The pH of 
this aqueous solution was < 3.0, which contributed to maintain antho-
cyanin stability. CE-NADES and CE-SORG extracts were stored at − 20 ◦C 
until the end of the experiments. 
2.4. Animals and pharmacokinetic study 
Sixty-four adult male Wistar rats (200–250 g) were provided by the 
Central Animal House of Federal University of Santa Maria (UFSM, RS). 
All procedures adopted were approved by the Committee for Care and 
Use of Experimental Animal Resources/UFSM (protocol number 
3253100219/2019). Animals were housed in standard polypropylene 
cages (four rats/cage) and kept under controlled temperature (22 ±
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2 ◦C) and humidity (55 ± 5%) and a 12/12 h light/dark cycle with access 
to food and water ad libitum. Rats were allowed free access to water and 
food throughout the experimental period and the crude blueberry 
extract was administered in the morning. No fasting was conducted 
before or after extract administration. Animals were randomly divided 
into experimental groups as follows: 
(I) Crude blueberry extract obtained using NADES (CE-NADES): 
received 9.1 mL of CE-NADES/kg body weight (b.w.) by gavage, 
amounting to 10.0 mg of total phenolic compounds/kg b.w. 
(II) Crude blueberry extract obtained using organic solvent (CE- 
SORG): received 9.1 mL of CE-SORG/kg b.w. by gavage, amounting to 
10.0 mg of total phenolic compounds/kg b.w. 
This dose was chosen based on a previous study from our research 
group where CE-NADES at the dose of 10 mg of total phenolic com-
pounds/kg b.w. was able to modulate the production of short-chain fatty 
acids by the rat gut microbiota (Silva, Rodrigues et al., 2020b). Animals 
were anesthetized with isoflurane and euthanized by exsanguination at 
15, 30, 60, 120, 240, 360 or 720 min after CE administration (n = 4/per 
time and n = 28/per treatment). Intracardiac blood and cecal feces were 
collected from each animal. Cecal feces were stored in liquid nitrogen 
until analysis, whereas blood was immediately processed to obtain 
plasma samples. In order to obtain baseline values (t0), eight control rats 
were fed 2 mL of distilled water/kg b.w. by gavage and samples were 
similarly collected. 
2.5. In vitro simulation of gastrointestinal digestion by INFOGEST method 
The harmonized static in vitro digestion model proposed by INFO-
GEST was used to investigate the stability and bioaccessibility of 
phenolic compounds from CE-NADES and CE-SORG extracts during 
digestion. CE-NADES and CE-SORG were the same extracts used in the in 
vivo experiment, which means that they had the same phenolic con-
centration. CE-NADES was the NADES-containing extract, whereas CE- 
SORG was an aqueous solution (pH < 3.0). Human digestion was 
simulated by sequential static steps according to the guidelines proposed 
by Brodkorb et al. (2019), except that gastric lipase was omitted as the 
extracts had no lipids. To simulate the digestive process after gavage 
(similar to the in vivo assay) the oral phase was omitted. The gastric 
phase was simulated by incubating extracts (5 mL) with simulated 
gastric fluid (pH 3.0) and 2000 U/mL pepsin at 37 ◦C for 2 h under 
shaking (final volume 10 mL). No HCl was required to adjust gastric pH 
to 3.0. After gastric digestion, the simulated intestinal fluid was added to 
the gastric chyme and the initial intestinal pH was measured and 
adjusted to 7.0 using 5 M NaOH at varying amounts according to the 
samples. Thereafter, intestinal digestion was simulated by adding bile 
salts (10 mM) and pancreatin (100 U/mL) and incubating at 37 ◦C for 2 h 
under shaking (final volume 28 mL) (Brodkorb et al., 2019). At the end 
of incubation, the intestinal digesta was centrifuged at 1500×g for 10 
min and two fractions were obtained: the supernatant, which represents 
the soluble/bioaccessible fraction of the digesta, and the sediment, 
which represents the insoluble/non-bioaccessible fraction. 
Aliquots of 2 g were withdrawn at the end of the gastric phase and 
from each intestinal fraction and were snap frozen in liquid nitrogen and 
stored at − 80 ◦C until chromatographic analysis. After collection of the 
gastric phase sample, the amount of incubation medium remaining was 
assessed by weighing and taken into account to correct the amount of 
salts and enzymes to be added in the intestinal phase to maintain the 
protocol described by Brodkorb et al. (2019). 
The bioaccessibility index of phenolic compounds was calculated as the 
amount of compounds recovered in the bioaccessible fraction after intes-
tinal digestion (B fraction) relative to the amount of compounds in the 
undigested extract and was calculated using the following equation (1): 
Bioaccessibility(%) = (B fraction/undigested extract) × 100  
2.6. Extraction of phenolic compounds and their metabolites from 
plasma, cecal feces and gastrointestinal digesta 
Fresh blood samples were collected in heparinized tubes and 
immediately centrifuged at 3000×g for 10 min. Plasma samples were 
extracted as described by He et al. (2006) and summarized below. 
Samples were mixed with an aqueous solution of 0.44 mol/L TFA (1:0.2, 
v/v) for acidification of this fluid and precipitation of proteins. Then, 
samples were centrifuged for 10 min at 3000×g and the supernatant was 
collected and stored in liquid nitrogen before SPE purification. 
The sediment representing the non-bioaccessible fraction obtained 
after in vitro digestion was extracted with methanol:water:formic acid 
(85:15:0.5, v/v/v) as described by Quatrin et al. (2020), the solvent was 
evaporated and samples were purified by SPE as described below. 
Deproteinized plasma samples, undigested extracts (CE-NADES and 
CE-SORG) and aliquots from gastric and intestinal phases (bioaccessible 
and non-bioaccessible fractions) were purified by C18 SPE according to 
He et al. (2006) with the following modifications. Samples of plasma 
(1.5 mL, after deproteinization), undigested extracts (0.2 mL) and 
gastric (0.2 mL) and intestinal phase fractions (0.8 mL) were applied to 
Sep-Pak® C18 cartridges (Waters, Massachusetts, USA) previously 
activated with methanol (6 mL) and preconditioned with 1% (v/v) TFA 
aqueous solution (12 mL). After sample loading, the cartridges were 
successively washed with 12 mL of 1% TFA aqueous solution to remove 
polar interfering compounds. Samples were eluted with two volumes of 
ethyl acetate to release the less polar phenolic compounds (hydrox-
ybenzoate derivatives, flavonols, hydroxycinnamate derivatives and 
metabolites) and thereafter with methanol acidified with 1% (v/v) TFA 
to release anthocyanins. Solvents were evaporated using a rotary 
evaporator (Bûchi-R3TM, Flawil, Switzerland) at 38 ± 2 ◦C and samples 
were adjusted to a known volume using acidified water (0.35% formic 
acid, v/v) for the anthocyanin fraction and 10% methanol in acidified 
water (0.1% formic acid; v/v) for the non-anthocyanin phenolic com-
pound fraction. Before LC analysis, purified extracts were filtered 
through a 0.22 μm PTFE syringe filter (Millipore®, São Paulo, Brazil). 
Anthocyanins and non-anthocyanin phenolic compounds were 
extracted from cecal feces according to He, Magnuson, and Giusti (2005) 
with the modifications described below. Feces samples (0.5 g) were 
extracted with 10 mL of a mixture containing methanol, water and TFA 
(60:40:1, v/v/v). Samples were subjected to an ultrasonic bath (40 kHz, 
3 min) and centrifuged for 10 min at 2500×g. The supernatant was 
collected, and the pellet was re-extracted twice with 10 mL of extraction 
solvent following the same procedure described above. Supernatants 
were combined and evaporated in a rotary evaporator at 38 ± 2 ◦C. After 
evaporation, the solution was diluted with 4 mL of acidified water (0.1% 
formic acid, v/v) and then 2 mL was applied to an SPE cartridges for 
purification as described for deproteinized plasma samples. 
2.7. Identification and quantification of polyphenols and their metabolites 
by LC-ESI-MS/MS and LC/DAD/UV–vis 
The identification of anthocyanins, phenolic compounds, and their 
metabolites was performed in a high-performance LC connected in series 
to a diode array detector (DAD; SPD-M20A) and a mass spectrometer 
(MS) with a quadrupole-time-of-fly (QTOF) analyzer and an electro-
spray ionization (ESI) source (model micrOTOF-Q II, Bruker Daltonics, 
Bremen, Germany). The MS parameters and tentative identification 
were performed as described by Silva, Pauletto et al. (2020a) and 
Quatrin et al. (2019). The tentative identification was based on their 
MS/MS and DAD/UV/vis spectral data and their elution order compared 
to the available standards and literature data. 
Anthocyanins were quantified using an LC (Shimadzu, Columbia, 
MD, USA) with a reverse-phase Symmetry C-18 column (2.6 μm particle 
size, 100 mm, 4.6 mm; Phenomenex, Torrance, CA, USA) and coupled to 
an UV–visible detector (SPD-20AV, Shimadzu, Columbia, MD, USA) in 
the analytical conditions validated by Silva, Pauletto et al. (2020a). 
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Anthocyanins in CE-NADES, CE-SORG, undigested extracts, gastric and 
intestinal phase fractions, plasma and cecal feces were quantified at 520 
nm as equivalents of cyanidin 3-glucoside. 
Due to the complex structure of non-anthocyanin phenolics and their 
metabolites, the quantification of these compounds was done using an 
LC (CBM-20A Prominence, Shimadzu, Kyoto, Japan) equipped with a 
degasser (DGU20A5 prominence, Shimadzu, Japan) and column oven 
(CTO-20A Prominence, Shimadzu, Japan) and coupled to a DAD (SPDM- 
20A Prominence, Shimadzu, Japan). Separation was performed in a 
reverse-phase C-18 Hypersil Gold column (5 μm particle size, 150 mm, 
4.6 mm; Thermo Fisher Scientific, MA, USA) at 38 ◦C, according to the 
method previously validated by Quatrin et al. (2019) in our laboratory. 
In CE-NADES, CE-SORG, undigested extracts, and gastric and intestinal 
phase fractions, non-anthocyanin phenolic compounds such as hydrox-
ybenzoate, hydroxycinnamate and flavan-3-ol derivatives were quanti-
fied at 280 nm as equivalents of catechin, whereas flavonol derivatives 
were quantified at 360 nm as equivalents of quercetin. In plasma and 
cecal feces, phenolic compounds such as hydroxybenzoic acid de-
rivatives were quantified at 280 nm as equivalents of their respective 
parent phenolic acid standard (vanillic acid or gallic acid). Valer-
olactone compounds and hippuric acid in plasma and cecal samples 
were quantified at 280 nm as equivalents of gallic acid. Hydroxycin-
namic acid derivatives were quantified at 320 nm as equivalents of their 
respective parent phenolic acid standard (p-coumaric acid or ferulic 
acid). 
2.8. Accuracy and precision 
The precision and accuracy assays followed the Brazilian Health 
Regulatory Agency Guidelines (ANVISA Agência Nacional de Vigilância 
Sanitária, 2017). Accuracy was assessed as the recovery after sample 
spiking with phenolic standards from two different classes. Vanillic acid 
was used to assess the recovery of hydroxybenzoic acid derivatives, 
whereas ferulic acid was used to assess the recovery of hydroxycinnamic 
acid derivatives. In this recovery test, samples of plasma and feces were 
fortified with the standards at a low, medium or high level, which cor-
responded to 80%, 100% and 120% of the amount of phenolic com-
pounds found in samples. In addition, recovery was also determined by 
spiking plasma and fecal samples with an amount of CE-NADES to result 
in a known concentration of anthocyanins (1561.0 µg/mL for plasma 
and 791.3 µg/g for cecal feces) and of non-anthocyanin compounds 
(1516.8 µg/mL for plasma and 743.6 µg/g for cecal feces). The sum of 
peak areas for anthocyanin or non-anthocyanin compounds in spiked 
plasma and feces samples was compared with CE-NADES, after sub-
tracting the area of blank plasma and feces samples. Recovery was 
assessed for triplicate determinations at each concentration level and 
was calculated as (total amount recovered/total amount added) ×
100%; and showed acceptable values for the methods used (Supple-
mentary Tables 1S and 2S). 
The precision of the method was determined as the repeatability 
(intra-day) and intermediate precision (inter-day) at the same condi-
tions used in the recovery assays. The precision of the method was 
calculated by measuring the areas of the peaks of vanillic and ferulic 
acids obtained from triplicate determinations of a sample fortified at 
three different concentration levels (low, medium or high) on the same 
day (repeatability) and in different days (intermediate precision) and 
was represented as the relative standard deviation (RSD%) from peak 
area values of phenolic compounds (Supplementary Tables 1S and 3S). 
2.9. Statistical analysis 
Pharmacokinetic parameters such as the maximum plasma concen-
tration (Cmax), time at which maximum plasma concentration is ach-
ieved (Tmax), area under the plasma concentration–time curve (AUC0- 
720min), half-life (t1/2), mean residence time (MRT), lambda_z and 
clearance (CL) were calculated by non-compartmental analysis using 
PKSolver software. Fractional bioavailability was calculated for antho-
cyanins based on parent compounds maintaining the parent C6-C3-C6 
flavonoid structure in blood relative to the amount ingested through 
the extracts. The results were statistically analyzed using Statistica V.7 
software (Statsoft Inc., Tulsa, OK, USA). Data were expressed as the 
mean ± standard error (SEM). Differences between means were 
analyzed by Student’s t test and a significant difference was considered 
at the level of p ≤ 0.05. Pearson’s correlation was run to investigate the 
association between the initial intestinal pH or the amount of NaOH to 
adjust intestinal pH versus the content of phenolic compounds after 
intestinal digestion of CE-NADES and CE-SORG extracts. 
3. Results 
3.1. Composition of crude extracts CE-NADES and CE-SORG 
Blueberry extracts obtained with NADES or organic solvent were 
adjusted to the same concentration of total polyphenols that amounted 
to 1.10 mg/mL of extract. The anthocyanin-rich fraction had 0.32 mg of 
cyanidin-3-glucoside equivalents/mL of extract, whereas the non- 
anthocyanin phenolic fraction had 0.31 mg of catechin equivalents 
(hydroxybenzoate, hydroxycinnamate and flavan-3-ol derivatives)/mL 
and 0.47 mg of quercetin equivalents (flavonol derivatives)/mL of 
extract. 
The phenolic profiles of CE-NADES and CE-SORG extracts were 
elucidated by LC-ESI-MS/MS and LC/DAD/UV–vis (Supplementary 
Fig. 1S and Table 4S). The tentative identifications based on the char-
acteristic DAD and MS/MS spectral data and the percentage of indi-
vidual phenolic compounds based on UV/vis peak areas are presented in 
Supplementary Table 4S. The phenolic profile was similar between CE- 
NADES and CE-SORG extracts. Concerning the anthocyanin profile, for 
both extracts delphinidin-3-hexoside and malvidin-3-hexoside/ 
delphinidin-3-acetylhexoside were the most abundant anthocyanins 
followed by cyanidin-3-galactoside, petunidin-3-hexoside, malvidin-3- 
pentoside, delphinidin-3-pentoside, petunidin-3-pentoside, malvidin 3- 
acetylhexoside, peonidin-3-pentoside, whereas other minor anthocya-
nins were found at concentrations lower than 1% of the total anthocy-
anin content. Among non-anthocyanin phenolic compounds, the 
chlorogenic acid isomer 3-caffeoylquinic acid was the major one fol-
lowed by quercetin-3-galactoside, quercetin-3-glucoside, myricetin-3- 
hexoside, quercetin-3-pentoside, 5-caffeoylquinic acid (chlorogenic 
acid isomer), quercetin 3-(6′ ′-acetyl)hexoside, catechin, laricitrin-3- 
hexoside, caffeoyl-O-hexoside, whereas other minor compounds were 
found at concentrations lower than 1% of the total non-anthocyanin 
phenolic compounds. It is noteworthy that the coefficient of variation 
for the relative amount of major phenolic compounds between CE- 
NADES and CE-SORG was lower than 10% of respective mean, indi-
cating no relevant differences between the two extracts (Supplementary 
Table 4S). The only exception was the amount of peonidin-3-pentoside 
that had a 12.7% coefficient of variation between the two extracts, 
being slightly more abundant in the CE-NADES extract (Supplementary 
Table 4S). 
3.2. Identification and chromatographic profile of polyphenols and its 
metabolites in plasma and cecal feces after CE-NADES or CE-SORG 
administration 
After the administration of a single oral dose of CE-NADES or CE- 
SORG to rats, a total of 28 possible phenolic metabolites were identi-
fied, 21 of which were detected in plasma and 19 in cecal feces samples 
(Table 1). The identification was performed at the time of highest con-
centration in plasma (120 min for CE-NADES and 15 min for CE-SORG) 
and cecal feces samples (360 min for both extracts). The chromato-
graphic profile of plasma and cecal feces is shown in Supplementary 
(Fig. 2S–5S). 
Nine anthocyanins were identified in plasma samples in their intact 
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form after the administration of crude blueberry extract: delphinidin-3- 
hexoside, malvidin-3-hexoside, cyanidin-3-galactoside, malvidin-3- 
pentoside, delphinidin-3-pentoside, malvidin 3-acetylhexoside, 
peonidin-3-pentoside, petunidin-3-pentoside and petunidin-3- 
acetylhexoside (Table 1). No anthocyanins were found in plasma sam-
ples at the baseline time (t0) (Supplementary Fig. 2S, panel A). Among 
metabolites identified in the plasma samples at the baseline time and 
after the administration of blueberry extracts we found amino acids 
(tyrosine, phenylalanine, tryptophan and N-phenylacetylglycine), 
phenolic acids resulting from the degradation of anthocyanins (gallic 
acid, vanillic acid and protocatechuic acid), compounds that are likely 
bacterial metabolites or products of intestinal esterases (dihy-
drocoumaric acid, ferulic acid, (3-(3-hydroxyphenyl) propanoic acid 
and hippuric acid) and organic acids (citric acid) (Table 1 and Supple-
mentary Fig. 4S). Although some metabolites were already found in 
baseline plasma samples, the levels of most of these metabolites changed 
after the administration of blueberry extracts. In fact, only citric acid, 
tyrosine and N-phenylacetylglycine did not undergo changes in plasma 
samples after administration of CE-NADES or CE-SORG. 
Only four anthocyanins were identified in their intact form in cecal 
Table 1 
Anthocyanins, phenolic acids and other metabolites identified in rat plasma and feces after administration of crude extracts of blueberry (CE-NADES or CE-SORG).  
Compounds Sample Rt (min)a λmax (nm)b Experimental MSc Experimental fragments Identification 
Anthocyanins       
Delphinidin 3-hexoside P, F  3.6 220; 521  465.0862 303.0410 MS/MS PUB 
Delphinidin 3-pentoside P, F  5.4 220; 520  435.0781 303.0500 MS/MS PUB 
Cyanidin 3-galactosided P  5.8 220; 510  449.0946 287.0458 MS/MS PUB 
Petunidin 3-hexoside F  7.5 220; 521  479.1021 317.0561 MS/MS PUB 
NI P  8.0 221; 506  – – – 
NI* F  9.5 n.d  – – – 
NI* F  10.3 n.d  – – – 
NI* F  10.5 n.d  – – – 
Petunidin 3-pentoside P, F  11.8 202; 522  449.0948 317.0552 MS/MS PUB 
Malvidin 3-hexoside P  13.3 220; 526  493.1186 331.0707 MS/MS PUB 
Peonidin 3-pentoside P  13.7 220; 521  433.0983 301.0597 MS/MS PUB 
Malvidin 3-pentoside P  15.1 220; 528  463.1101 331.0714 MS/MS PUB 
Petunidin 3-acetylhexoside P  16.3 220; 527  521.1142 317.0557 MS/MS PUB 
Malvidin 3-acetylhexoside P  17.4 220; 528  535.1293 331.0719 MS/MS PUB  
Hydroxybenzoic acid derivatives       
Gallic acid P, F  3.8 207; 270  169.0124 125.0225 STD 
Protocatechuic acid P, F  6.9 259; 293  153.0221 109.0315; 108.0233 STD 
NIe P, F  10.9 214; 277  181.0518 135.0415 – 
Vanillic acid P, F  14.5 259; 292  167.0335 152.0134; 108.0176 STD  
Hippuric acids       
Hippuric acid P, F  13.6 195; 247  178.0519 134.0619 MS/MS PUB  
Hydroxycinnamic acid derivatives       
NIe F  16.6 201; 307  207.0675 102.9992 – 
Dihydrocoumaric acid P, F  25.9 217; 288  165.0563 119.0472; 121.0560 MS/MS PUB 
Dihydroferulic acid F  31.4 222; 276  195.0673 136.0503 MS/MS PUB 
Ferulic acid P, F  34.4 264; 321  193.0500 134.1061 STD 
NI F  37.6 n.d  243.1251 163.1116; 119.0507 –  
Phenylpropionic acids       
3-(3-Hydroxyphenyl) propanoic acid P, F  30.4 216; 274  165.0557 121.0520 MS/MS PUB 
Amino acids       
Tyrosinee P  3.3 195; 274  180.0678 163.0444; 147.0449; 112.9875 MS/MS PUB 
Phenylalanine P, F  5.9 193; 276  164.0728 147.0429; 119.0407 MS/MS PUB 
Tryptophan P, F  9.7 216; 278  203.0840 116.0518; 142.0655; 159.0957 MS/MS PUB 
N-Phenylacetylglycinee P  17.5 194  192.0203 121.0299 MS/MS PUB  
Phenylacetic acids       
3́-Hydroxyphenylacetic acid F  14.2 213; 275  151.0501 107.0440 MS/MS PUB  
Valerolactones       
5-(3ʹ,4ʹ-Dihydroxyphenyl)-γ-valerolactone F  15.3 216; 289  206.0462 162.0551; 147.0322; 118.0287 MS/MS PUB  
Carboxylic acids       
Citric acide P  2.9 194; 208  191.0223 111.0112 MS/MS PUB 
Indole-2- carboxylic acid F  11.5 201; 256; 336  160.0416 159.0331; 131.0378 MS/MS PUB 
5-Hydroxyindole-3-acetate F  24.3 n.d  190.0515 146.0640 MS/MS PUB 
NI P  36.6 n.d  204.0683 – – 
Azelaic acid F  52.4 n.d  187.0980 125.0967 MS/MS PUB  
Others organic compounds       
NI P  27.1 n.d  283.0851 – –  
a Retention time on the C18 Phenomenex (2.6 μm; 100 × 4.6 mm) column for anthocyanins (elution gradient of 3% formic acid in water and pure acetonitrile) and on 
the C18 Thermo Fisher Scientific (5 μm; 150 × 4.6 mm) column for non-anthocyanin compounds (elution gradient of 5% methanol in acidified water (0.1% formic acid) 
and acetonitrile with 0.1% formic acid). b Wavelength of maximum UV–vis absorption. c Experimental MS corresponds to m/z [M]+ for anthocyanins and m/z [M− H]−
for non-anthocyanin compounds. d Galactoside sugar identified by comparison with the retention time of cyanidin-3-glucoside standard. e Compounds that were found 
in t0 (baseline) samples and did not undergo concentration changes after CE-NADES or CE-SORG administration. CE-NADES: crude extract of blueberry obtained using 
NADES. CE-SORG: crude extract of blueberry obtained using organic solvent. P: plasma. F: cecal feces. STD: identification by comparing mass spectra and retention 
time to available standard. MS/MS PUB: tentative identification by prediction of chemical formula from exact mass and confirmation by comparing fragmentation 
mass spectra and UV–vis spectra with literature, in addition to the observed elution order relative to the available standards. NI: not identified compound. NI*: not 
identified compound that was formed during the metabolism of phenolics because it did not appear at t0. nd: not detected. 
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feces after the administration of crude blueberry extracts: delphinidin-3- 
hexoside, delphinidin-3-pentoside, petunidin-3-hexoside and petunidin- 
3-pentoside (Table 1 and Supplementary Fig. 3S). As observed for 
plasma samples, anthocyanins were not detected in feces samples at t0 
(Supplementary Fig. 3S, panel A). Among the 15 remaining metabolites 
found in cecal samples, we identified gallic acid, hippuric acid, vanillic 
acid, protocatechuic acid, dihydrocoumaric acid, ferulic acid, dihy-
droferulic acid, 5-(3ʹ,4ʹ-dihydroxyphenyl)-γ-valerolactone, 3-(3- 
hydroxyphenyl) propanoic acid and 3ʹ -hydroxyphenyl acetic acid as 
degradation products of anthocyanins and possible bacterial metabolites 
(Table 1). In addition, we found carboxylic acids, namely indole-2- 
carboxylic acid, 5-hydroxyindole-3-acetate and azelaic acid, and 
amino acids such as tryptophan and phenylalanine (Table 1, Supple-
mentary Fig. 5S). Some of these identified fecal metabolites underwent 
increases after administration of CE-NADES or CE-SORG as presented in 
section 3.3. 
3.3. Pharmacokinetic analysis and determination of phenolic compounds 
and their metabolites in cecal feces after CE-NADES or CE-SORG 
administration 
After a single oral dose (10 mg of total polyphenols/kg b.w.), an-
thocyanins reached the maximum concentration in plasma 15 min after 
CE-SORG administration, while for the CE-NADES group the maximum 
plasma concentration was reached at 120 min (p ≤ 0.05; Fig. 1A). The 
plasma chromatographic profiles at t0 (baseline), t120 for CE-NADES 
and t15 for CE-SORG are shown in Supplementary Fig. 2S. The phar-
macokinetic parameters of phenolic compounds were estimated by 
applying a non-compartmental model (Table 2). The Tmax, mean half-life 
(t1/2), AUC0-720 min and MRT of anthocyanins were significantly higher 
for CE-NADES than for CE-SORG (p ≤ 0.05). Concerning the mean 
values estimated for the pharmacokinetic parameters of elimination, CL 
and Lambda_z were significantly smaller for CE-NADES than for the CE- 
SORG group (p ≤ 0.05). Although the maximum plasma concentration 
of anthocyanins (Cmax) did not differ between the two extracts, the 
bioavailability of anthocyanins from CE-NADES was 140% greater when 
compared to the CE-SORG group (0.82 vs. 0.34%, p ≤ 0.05, respectively; 
Table 2). 
The plasma curves of five selected phenolic acids are presented in 
Fig. 1 (panels B to F). Gallic acid, vanillic acid, ferulic acid, hippuric acid 
and dihydrocoumaric acid were detected in plasma at the baseline time 
(t0) probably due to the phytochemical composition of the animal feed 
(Supplementary Fig. 4S, panel A). For these compounds, it was not 
possible to calculate pharmacokinetic parameters such as t1/2, MRT, 
lambda_z, and CL by PKSolver software because they were detected at 
fewer than three time points along the elimination terminal phase and 
the concentration in this phase showed an ascending tendency. 
Among the analyzed parameters, there was no significant difference 
in Tmax for gallic acid and hippuric acid between CE-NADES and CE- 
SORG groups. However, the Tmax obtained in the CE-NADES group 
was significantly higher for vanillic and ferulic acids when compared to 
that for the CE-SORG group. Only for dihydrocoumaric acid, Tmax was 
higher in the CE-SORG than CE-NADES group (720.0 vs. 52.5 min, p ≤
0.05). No significant differences were observed in Cmax of phenolic acids 
between the CE-NADES and CE-SORG groups. Only the AUC0-720 min of 
gallic acid was higher for CE-SORG in comparison to the CE-NADES 
group (p ≤ 0.05), whereas the other phenolic acids showed no differ-
ences in AUC0-720 min between the CE-NADES and CE-SORG groups. 
The fecal concentration of anthocyanins after a single administration 
of CE-NADES or CE-SORG is presented in Fig. 2A. Anthocyanins were 
first detected in cecal feces only at 120 min after extract administration 
for the CE-NADES group and at 240 min for the CE-SORG group (Fig. 2A, 
Fig. 1. Plasma profile for total anthocyanins, phenolic acids and their metabolites after a single oral administration of CE-NADES or CE-SORG extract to rats: total 
anthocyanins (A); gallic acid (B); vanillic acid (C); ferulic acid (D); dihydrocoumaric acid (E); hippuric acid (F). Data are presented as mean ± SEM (n = 4). *Indicates 
difference compared to the CE-SORG group at the same time point, p ≤ 0.05 (Student’s t test). CE-NADES: crude extract of blueberry obtained using NADES. CE- 
SORG: crude extract of blueberry obtained using organic solvent. 
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p ≤ 0.05). Thus, the CE-NADES group had higher fecal concentration of 
anthocyanins than the CE-SORG group at 120 min (p ≤ 0.05) but no 
differences between groups were detected at the other time points. The 
chromatographic profile of anthocyanins in cecal feces at t0 (baseline), 
t360 for CE-NADES and t360 for CE-SORG is shown in Supplementary 
Fig. 3S). 
Just like in plasma, phenolic compounds were detected in cecal feces 
at t0 (Supplementary Fig. 5S, panel A). In general, most non- 
anthocyanin phenolic compounds showed a higher fecal concentration 
in the CE-NADES group than in the CE-SORG group (Fig. 2, panels B–E). 
Compared to the CE-SORG group, the CE-NADES group had a signifi-
cantly higher fecal concentration of vanillic acid (at 360 min after 
administration; Fig. 2B), ferulic acid (at 30, 60, 240 and 360 min after 
administration; Fig. 2C) and hippuric acid (at 60 min after administra-
tion; Fig. 2E) but a significantly lower concentration of 5-(3ʹ,4ʹ-dihy-
droxyphenyl)-γ-valerolactone (at 30, 60 and 720 min after 
administration; Fig. 2D). Dihydro ferulic acid and 3ʹ -hydroxyphenyl 
acetic acid were detected in cecal feces but were below the limit of 
quantification. 
3.4. In vitro gastrointestinal digestion of phenolic compounds from CE- 
NADES and CE-SORG blueberry extracts 
An in vitro sequential gastrointestinal digestion assay was conducted 
to investigate differences in the stability and bioaccessibility of phenolic 
compounds between CE-NADES and CE-SORG (Fig. 3). Before digestion, 
CE-NADES and CE-SORG extracts showed a similar content of antho-
cyanins (290.1 vs 301.2 µg equivalents of cyanidin-3-glucoside/mL of 
extract) and non-anthocyanin phenolic compounds (949.6 vs 945.8 µg 
sum of catechin and quercetin equivalents/mL of extract, respectively) 
(Fig. 3, panels A and C). Anthocyanins underwent degradation during 
gastric digestion (Fig. 3A), but there was a higher degree of degradation 
of non-anthocyanin phenolics during gastric digestion (Fig. 3C). How-
ever, no differences were observed in the content of anthocyanin or non- 
anthocyanin phenolic compounds between CE-NADES and CE-SORG 
after simulation of gastric phase digestion (Fig. 3, panels A and C). 
Interestingly, after adding simulated intestinal fluid, the amount of 
NaOH required to adjust to pH 7.0 was about 16 times higher for CE- 
NADES than for CE-SORG (3.09 ± 0.04 vs. 0.18 ± 0.02 mL of 5 M 
NaOH, respectively; p ≤ 0.05). After intestinal digestion there was 
extensive degradation of anthocyanin and non-anthocyanin phenolic 
compounds (Fig. 3, panels A and C). Moreover, after intestinal digestion, 
the content of anthocyanin and non-anthocyanin phenolic compounds 
was significantly higher for CE-NADES than for CE-SORG in the bio-
accessible and non-bioaccessible intestinal fractions (Fig. 3, panels B and 
D). The intestinal bioaccessibility of phenolic compounds was remark-
ably increased in CE-NADES compared to CE-SORG, being about 35-fold 
higher for anthocyanins (21.6 ± 0.1% vs 0.6 ± 0.2%, respectively; p ≤
0.05) and 5-fold higher for non-anthocyanin phenolics (20.5 ± 5.5% vs 
3.3 ± 0.1%, respectively; p ≤ 0.05). 
Pearson’s correlation analysis revealed that a higher content of 
phenolic compounds at the end of intestinal digestion was associated 
with a lower initial intestinal pH (R2 = -0.9985 for anthocyanins and 
− 0.8951 for non-anthocyanin phenolics, p ≤ 0.05) and a higher amount 
of NaOH required to reach intestinal pH 7.0 (R2 = 0.9994 for anthocy-
anins and 0.8771 for non-anthocyanin compounds, p ≤ 0.05) (Supple-
mentary Table 5S). 
4. Discussion 
In the present study, we demonstrated that the extraction of blue-
berry polyphenols using NADES produces a ready-to-use extract that has 
higher oral bioavailability for anthocyanins in rats when compared to 
the extract obtained using organic solvent. These findings confirm the 
hypothesis of the study and reveal a great advantage of NADES extracts 
over those obtained using organic solvents, which additionally require 
removal of solvent and resuspension in water before human or animal 
use. Such effect was obtained for the NADES mixture composed of 
choline chloride:glycerol:citric acid (0.5:2:0.5, molar ratio) plus 25% 
water, which was recently demonstrated to be as effective as organic 
solvents into extracting blueberry anthocyanins (Silva, Pauletto et al., 
2020a). However, it is important to highlight that these results cannot be 
directly generalized to all NADES because of the large differences in 
NADES composition. In addition, subsequent studies should evaluate 
whether the effect of NADES on the bioavailability of phenolic com-
pounds is dependent on the dose of NADES or phenolic compounds. 
Intact glycosylated forms of anthocyanins were detected in the 
plasma of rats after administration of CE-NADES or CE-SORG, which is 
in line with previous reports for blueberry (Baron et al., 2017; Ichiya-
nagi, Shida, Rahman, Hatano, & Konishi, 2006). The non- 
compartmental pharmacokinetic parameters of anthocyanins were 
significantly different between CE-NADES and CE-SORG groups. Animal 
model studies indicate that bilberry anthocyanins are rapidly absorbed, 
appearing in the bloodstream within few minutes (6 to 20 min) after 
consumption (Ichiyanagi et al., 2006). In the CE-SORG group, where the 
previously dried extract was redissolved in water before administration 
to rats, the Tmax of anthocyanins in plasma was 15 min, which is in 
accordance with Baron et al. (2017). However, the CE-NADES group 
displayed a biphasic profile for anthocyanin absorption that was char-
acterized by a low plasma peak at 15 min followed by a high peak at 120 
Table 2 
Pharmacokinetic parameters of phenolic compounds following oral adminis-
tration of CE-NADES or CE-SORG extracts.  
Pharmacokinetic parameter CE-NADES CE-SORG 
Total anthocyanins   
Tmax (min) 120.0 ± 0.0* 15.0 ± 0.0 
Cmax (ng/mL) 40.0 ± 0.8 44.6 ± 3.3 
t1/2 (min) 141.6 ± 3.2* 45.1 ± 9.2 
AUC 0-720 min (ng/mL × min) 5351.0 ± 267.2* 2599.0 ± 178.0 
MRT (min) 162.6 ± 1.1* 76.8 ± 13.1 
Lambda_z (1/min) 0.005 ± 0.000* 0.015 ± 0.003 
CL [(mg/kg)/(ng/mL)/min] 0.0005 ± 0.0000* 0.0009 ± 0.0000 
Bioavailability (%) 0.82 ± 0.05* 0.34 ± 0.02  
Phenolic acids   
Gallic acid   
Tmax (min) 82.1 ± 0.2 108.8 ± 10.5 
Cmax (ng/mL) 145.5 ± 10.9 230.5 ± 49.3 
AUC 0-720 min (ng/mL × min) 36058.0 ± 267.2* 74453.4 ± 6576.1  
Vanillic acid   
Tmax (min) 120.0 ± 0.0* 56.3 ± 10.2 
Cmax (ng/mL) 27.0 ± 2.5 33.9 ± 5.2 
AUC 0-720 min (ng/mL × min) 6458.9 ± 390.6 6772.9 ± 464.8  
Ferulic acid   
Tmax (min) 720.0 ± 0.0* 60.0 ± 0.0 
Cmax (ng/mL) 51.6 ± 4.1 58.4 ± 4.0 
AUC 0-720 min (ng/mL × min) 23837.1 ± 1110.7 15954.8 ± 1423.8  
Hippuric acid   
Tmax (min) 720.0 ± 0.0 720.0 ± 0.0 
Cmax (ng/mL) 43.9 ± 3.6 57.4 ± 4.9 
AUC 0-720 min (ng/mL × min) 16235.7 ± 1149.7 20011.7 ± 628.2  
Dihydrocoumaric acid   
Tmax (min) 52.5 ± 25.9* 720.0 ± 00.0 
Cmax (ng/mL) 21.6 ± 0.9 24.4 ± 7.3 
AUC 0-720 min (ng/mL × min) 8349.2 ± 459.1 9713.6 ± 1140.5 
Data are presented as mean ± SEM, n = 4. 
CE-NADES: crude extract of blueberry obtained using NADES. CE-SORG: crude 
extract of blueberry obtained using organic solvent. Tmax: time at which 
maximum plasma concentration is achieved. Cmax: maximum plasma concen-
tration. t1/2: elimination half-life. AUC0-720 min: area under the concentration vs. 
time curve. MRT: mean residence time. Lambda_z: individual estimate of the 
terminal elimination rate constant. CL: clearance. Bioavailability is the relative/ 
fractional bioavailability and was calculated using AUC0-720 min. * Indicates 
difference compared to the CE-SORG group, p ≤ 0.05 (Student’s t test). 
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min after CE-NADES administration. It is not possible to definitively 
explain this behavior. However, the first peak (15 min) could be likely 
attributed to the gastric absorption of anthocyanins, whereas the second 
peak at 120 min could be interpreted as enterohepatic recirculation, 
which is characterized by the secretion of compounds retained in the 
bile into the duodenum and their subsequent reabsorption (Fang, 2014; 
Zhong et al., 2017). This phenomenon has already been reported for 
intact anthocyanins (Stalmach, Edwards, Wightman, & Crozier, 2012) 
and monoglucuronide metabolites (Zhong et al., 2017), but this is the 
first study showing that NADES seems to favor a biphasic absorption 
profile for phenolic compounds. 
Based on the pharmacokinetic characteristics, namely t1/2, MRT, 
lambda_z and CL, CE-NADES increased the extent to which anthocyanins 
were absorbed and delayed their elimination. AUC is the most reliable 
measure of a compound’s bioavailability because it is directly propor-
tional to the total amount of an unaltered analyte that reaches the sys-
temic circulation (Le, 2017). While the time versus concentration curves 
demonstrated that CE-NADES and CE-SORG groups achieved the same 
maximum plasma concentration of anthocyanins, the AUC0-720 min and 
consequently the bioavailability of anthocyanins were remarkably 
higher in the CE-NADES group. These differences may be attributed to 
the delayed elimination and longer plasma permanence of anthocyanins 
(t1/2, MRT, lambda_z and CL). Similar data were found when a proline: 
glutamic acid NADES was used as a vehicle for rutin administration to 
rats (Faggian et al., 2016), whereas honey that has NADES properties 
has been demonstrated to increase the plasma peak of calycosin-7-O-β-d- 
glucoside from Astragali radix (Dai et al., 2020). Another NADES mixture 
based on L-proline-malic acid also increased the bioavailability of iso-
flavones from the root of Pueraria lobata (Huang et al., 2021), whereas L- 
proline:acetamide has been shown to increase plasma peak of qui-
nochalcone C-glycosides from Carthamus tinctorius L. (Tong et al., 2021). 
However, the present study is the first one to assess the effect of NADES 
on the bioavailability of phenolic compounds in a ready-to-use fruit 
extract. Moreover, the influence of NADES on the bioavailability of 
anthocyanins and phenolic acids was also investigated for the first time. 
Compared to other flavonoid groups, the bioavailability of antho-
cyanins is very low (Hanske et al., 2013). The systemic bioavailability of 
anthocyanins ranges between 0.26% and 1.80% in animal studies and 
amounts to 1.09% in humans (Fang, 2014; Ichiyanagi et al., 2006; Zhong 
et al., 2017). Interestingly, we demonstrated that the bioavailability of 
total anthocyanin compounds maintaining their C6-C3-C6 structure was 
140% higher in the CE-NADES group than in the CE-SORG group. Since 
CE-NADES and CE-SORG had a similar phenolic composition and con-
centration, the improvement of absorption kinetics, together with the 
biphasic response profile can be attributed to the type of vehicle used, i. 
e. NADES for CE-NADES vs. water for CE-SORG. Sut et al. (2017) and 
Faggian et al. (2016) demonstrated that the increase in the bioavail-
ability of berberine (alkaloid) and rutin is related to the better solubi-
lization properties of different eutectic mixtures compared to aqueous 
suspensions. In fact, we have data showing that the solubility of 
anthocyanin compounds was increased by 20% in the NADES used in the 
present study when compared to water (Supplementary Fig. 6S). This 
finding suggests that the best solubility of anthocyanins in NADES may 
contribute to the increased bioavailability of anthocyanins. 
Moreover, we attribute the longer plasma permanence of anthocya-
nins to the sustained intestinal absorption due to increased stability of 
anthocyanins during gastrointestinal digestion in the CE-NADES group, 
when compared to CE-SORG. This hypothesis is supported by the greater 
stability and bioaccessibility of CE-NADES phenolics during in vitro in-
testinal digestion. In addition, CE-NADES group had higher fecal con-
centration of intact anthocyanins than CE-SORG group at 120 min, 
which is the time at which plasma levels of anthocyanins peak in the CE- 
NADES group. In vitro studies also corroborate that other NADES mix-
tures, namely a lactic acid–glucose–based NADES, are able to improve 
Fig. 2. Cecal feces concentrations of total anthocyanins, phenolic acids and their metabolites after a single oral administration of CE-NADES or CE-SORG extract to 
rats: total anthocyanins (A); vanillic acid (B); ferulic acid (C); 5-(3ʹ,4ʹ-dihydroxyphenyl)-γ-valerolactone (D); hippuric acid (E). Data are presented as mean ± SEM (n 
= 4). *Indicates difference compared to the CE-SORG group at the same time point, p ≤ 0.05 (Student’s t test). CE-NADES: crude extract of blueberry obtained using 
NADES. CE-SORG: crude extract of blueberry obtained using organic solvent. 
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the stability of cyanidin (Dai, Rozema, Verpoorte, & Choi, 2016). In fact, 
although anthocyanins are quite stable under the acid gastric pH, they 
have been shown to be extensively degraded under conditions that 
simulate small intestine digestion (Quatrin et al., 2020), as also observed 
in our in vitro digestion assay. Interestingly, the choline chloride:glyc-
erol:citric acid-based NADES reduced the initial intestinal pH and 
increased the amount of NaOH required to reach intestinal pH 7, which 
likely contributed to increased stability and bioaccessibility of pheno-
lics. Accordingly, correlation analysis revealed that the lower the initial 
intestinal pH, the higher the concentration of phenolic compounds 
recovered after intestinal digestion. 
We propose that the buffering effect of citric acid in NADES delayed 
the neutralization of gastric chyme by intestinal fluid and attenuated the 
pH-triggered degradation of phenolic compounds when passing from the 
gastric to the intestinal phase. Citric acid, which amounted to 50 mM in 
the intestinal phase, has buffering properties in the acidic range due to 
the presence of three carboxyl groups, whose pKa values adjusted to 
37 ◦C are 3.1, 4.71 and 6.42 (Martell & Smith, 1977). While food 
acidulants have recently been demonstrated to increase the bio-
accessibility of some polyphenols from grains (Hithamani & Srinivasan, 
2017), this is the first study describing the effect of a NADES on the 
bioaccessibility of phenolic compounds and proposing that organic acids 
increase the stability and bioaccessibility of phenolic compounds. 
The metabolic fate of anthocyanins is complex, and metabolites 
produced after anthocyanin absorption may return to the gut lumen via 
the enterohepatic circulation (in bile) (Zhong et al., 2017). Thus, one 
cannot rule out the hypothesis that CE-NADES also promotes higher and 
earlier gastric absorption of anthocyanins followed by bile excretion and 
subsequent recycling via enterohepatic circulation. Together with the 
non-absorbed anthocyanins, systemic anthocyanin metabolites excreted 
through the bile will reach the colon where all these compounds can be 
converted into absorbable phenolic acids by the gut microbiota, or be 
directly excreted in the feces (Han et al., 2019). 
The intestinal microbiota plays an important role in the metabolism 
of polyphenols (Wang et al., 2015). Fig. 4 summarizes a proposal for the 
biotransformation of blueberry polyphenols during digestion and high-
lights the pathways favored by the NADES vehicle based on the present 
study. The fecal profile of anthocyanins was similar between CE-NADES 
and CE-SORG groups and revealed that only delphinidin-3-pentoside, 
cyanidin-3-galactoside and petunidin-3-hexoside remained intact after 
blueberry extract passed through the gastrointestinal tract. The un-
identified compounds found in feces are likely anthocyanin catabolites 
that may have originated during passage through the gastrointestinal 
tract or by the intestinal microbiota itself. After intestinal cleavage, 
anthocyanins are converted into aglycones that were not detected in the 
present study as they are highly unstable under physiological intestinal 
conditions, and therefore are rapidly metabolized into phenolic acids 
and phenolic aldehydes (Han et al., 2019; Hanske et al., 2013). 
Overall, CE-NADES resulted in a greater amount of phenolic acids in 
the feces of rats than CE-SORG. We cannot attribute a greater elimina-
tion of phenolic acids to the CE-NADES group since feces were collected 
from the cecum, a site of intense microbial activity and where these 
compounds may be highly subject to resorption before feces are elimi-
nated (Carabano, Badiola, Licois, & Gidenne, 2006). The changes in the 
phenolic composition of fecal samples triggered by NADES were not 
related to changes in fecal moisture. Although NADES contained glyc-
erol, a compound that can increase the amount of water in the intestinal 
lumen, facilitating fecal evacuation and consequently the elimination of 
water-soluble compounds (Wapnir, Sia, & Fisher, 1996), the moisture of 
the cecal content was not different between the CE-NADES an CE-SORG 
groups (78.9 ± 1.1% vs 79.2 ± 1.9%; p > 0.05). Most phenolic acids in 
cecal feces, returned to their initial concentration after 720 min in both 
Fig. 3. Changes in total anthocyanin (A, B) and non-anthocyanin phenolic compound (C, D) content during in vitro digestion of crude extracts of blueberry obtained 
using NADES (CE-NADES) or organic solvent followed by drying and reconstitution in water (CE-SORG). Samples assessed before (undigested samples) and after in 
vitro digestion (gastric and intestinal phases) are shown in panels A and C, whereas panels B and D show the distribution of compounds after intestinal digestion. B- 
fraction: bioaccessible fraction; NB-fraction: non-bioaccessible fraction; intestinal phase total: sum of bioaccessible (B-fraction) and non-bioaccessible (NB-fraction) 
fractions. Data are presented as mean ± SEM (n = 3). *Indicates difference compared to the CE-SORG group, p ≤ 0.05 (Student’s t test). Total anthocyanins are the 
sum of all anthocyanins (µg of cyanidin-3-glucoside equivalents), whereas non-anthocyanin phenolic compounds are expressed as the sum of hydroxybenzoate, 
hydroxycinnamate and flavan-3-ol derivatives (µg of catechin equivalents) and flavonol derivatives (µg of quercetin equivalents). 
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groups, which may be attributed to their biotransformation by the 
colonic microbiota into hippuric acid. 
Despite the appreciable amount of chlorogenic acid in crude blue-
berry extracts, this compound was not detected in the plasma or fecal 
samples of rats regardless of the extraction solvent. This finding in-
dicates extensive degradation of chlorogenic acid during digestion and is 
in line with previous data showing low bioavailability for this phenolic 
acid (around 0.22%), which has been demonstrated to be immediately 
cleaved into caffeic acid and quinic acid after reaching the large intes-
tine (Zhong et al., 2017). Caffeic acid may have been rapidly methylated 
to yield ferulic acid, which is metabolized to dihydroferulic acid in the 
colon (de Ferrars et al., 2014). CE-NADES appeared to have delayed the 
elimination of ferulic acid, since plasma peak levels were attained 660 
min after those for the CE-SORG group. This finding may be related to 
the intestinal metabolism of caffeic acid, yielding sustained ferulic acid 
production in the CE-NADES group. 
Hippuric acid, which has been described as one of the main end 
products of anthocyanin and non-anthocyanin phenolic acid metabo-
lization (Zhong et al., 2017), showed a large increase in plasma at 720 
min after the administration of CE-NADES or CE-SORG. By this time, 
most other phenolic acids had returned to baseline plasma levels, sug-
gesting that metabolites such as gallic and vanillic acids are likely 
metabolized to benzoic acid and subsequently conjugated to glycine to 
form hippuric acid (de Ferrars et al., 2014). Thus, hippuric acid is not 
only a baseline metabolite originating from animal feed phytochemicals 
but is also a late metabolite produce from blueberry phenolic 
compounds. 
5. Conclusion 
Compared to an organic solvent extract, the NADES-based crude 
extract of blueberry showed increased bioavailability of anthocyanins. 
This effect was related to increased intestinal stability of phenolic 
compounds by delayed neutralization of gastric chyme in the presence of 
NADES, which favors a biphasic absorption profile and increases the 
plasma permanence of anthocyanins. Thus, in addition to being 
biocompatible, choline chloride:glycerol:citric acid NADES has great 
potential to yield ready-to-use extracts that increase the bioavailability 
of fruit phenolic compounds. This finding reveals NADES as a powerful 
tool for the development of functional foods, nutraceuticals and phar-
macological formulations. 
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Duarte, M. C. T., Godoy, H. T., & Hermosín-Gutiérrez, I. (2016). Antimicrobial 
activity and differentiation of anthocyanin profiles of rabbiteye and highbush 
blueberries using HPLC–DAD–ESI-MSn and multivariate analysis. Journal of 
Functional Foods, 26, 506–516. https://doi.org/10.1016/j.jff.2016.07.026. 
Quatrin, A., Pauletto, R., Maurer, L. H., Minuzzi, N., Nichelle, S. M., Carvalho, J. F. C., … 
Emanuelli, T. (2019). Characterization and quantification of tannins, flavonols, 
anthocyanins and matrix-bound polyphenols from jaboticaba fruit peel: A 
comparison between Myrciaria trunciflora and M. jaboticaba. Journal of Food 
Composition and Analysis, 78, 59–74. https://doi.org/10.1016/j.jfca.2019.01.018. 
Quatrin, A., Rampelotto, C., Pauletto, R., Maurer, L. H., Nichelle, S. M., Klein, B., … 
Emanuelli, T. (2020). Bioaccessibility and catabolism of phenolic compounds from 
jaboticaba (Myrciaria trunciflora) fruit peel during in vitro gastrointestinal digestion 
and colonic fermentation. Journal of Functional Foods, 65, 103714. https://doi.org/ 
10.1016/j.jff.2019.103714. 
Rodriguez-Mateos, A., Feliciano, R. P., Cifuentes-Gomez, T., Spencer, J. P. E., 
Seeram, N. P., & Shukkitt-Hale, B. (2016). Bioavailability of wild blueberry (poly) 
phenols at different levels of intake. Journal of Berry Research, 6(2), 137–148. 
https://doi.org/10.3233/JBR-160123. 
Silva, D. T., Pauletto, R., Cavalheiro, S. D. S., Bochi, V. C., Rodrigues, E., Weber, J., … 
Emanuelli, T. (2020a). Natural deep eutectic solvents as a biocompatible tool for the 
extraction of blueberry anthocyanins. Journal of Food Composition and Analysis, 89, 
103470. https://doi.org/10.1016/j.jfca.2020.103470. 
Silva, D. T., Rodrigues, R. F., Machado, N. M., Maurer, L. H., Ferreira, L. F., Somacal, S., 
… Emanuelli, T. (2020b). Natural deep eutectic solvent (NADES)-based blueberry 
extracts protect against ethanol-induced gastric ulcer in rats. Food Research 
International, 138, 109718. https://doi.org/10.1016/j.foodres.2020.109718. 
Stalmach, A., Edwards, C. A., Wightman, J. D., & Crozier, A. (2012). Gastrointestinal 
stability and bioavailability of (poly)phenolic compounds following ingestion of 
Concord grape juice by humans. Molecular Nutrition & Food Research, 56(3), 
497–509. https://doi.org/10.1002/mnfr.201100566. 
Sut, S., Faggian, M., Baldan, V., Poloniato, G., Castagliuolo, I., Grabnar, I., Perissutti, B., 
Brun, P., Maggi, F., Voinovich, D., Peron, G., & Dall’Acqua, S. (2017). Natural deep 
eutectic solvents (NADES) to enhance berberine absorption: An in vivo 
pharmacokinetic study. Molecules, 22(11), 1921. https://doi.org/10.3390/ 
molecules22111921. 
Teng, H. & Chen, L. (2019). Polyphenols and bioavailability: an update. Critical Reviews 
in Food Science and Nutrition, 59(13), 2040-2051. https://doi:101080/ 
10408398.2018.1437023. 
Tong, X., Yang, J., Zhao, Y.u., Wan, H., He, Y.u., Zhang, L., … Li, C. (2021). Greener 
extraction process and enhanced in vivo bioavailability of bioactive components 
from Carthamus tinctorius L. by natural deep eutectic solvents. Food Chemistry, 348, 
129090. https://doi.org/10.1016/j.foodchem.2021.129090. 
Wang, D., Ho, L., Faith, J., Ono, K., Janle, E. M., Lachcik, P. J., … Pasinetti, G. M. (2015). 
Role of intestinal microbiota in the generation of polyphenol derived phenolic acid 
mediated attenuation of Alzheimer’s disease β-amyloid oligomerization. Molecular 
Nutrition & Food Research, 59(6), 1025–1040. 
Wapnir, R. A., Sia, M. C., & Fisher, S. E. (1996). Enhancement of intestinal water 
absorption and sodium transport by glycerol in rats. American Physiological Society, 
81(6), 2523–2527. https://doi.org/10.1152/jappl.1996.81.6.2523. 
Zhong, S., Sandhu, A., Edirisinghe, I., & Burton-Freeman, B. (2017). Characterization of 
wild blueberry polyphenols bioavailability and kinetic profile in plasma over 24-h 
period in human subjects. Molecular Nutrition & Food Research, 61(12), 1–13. https:// 
doi.org/10.1002/mnfr.201700405. 
D.T. da Silva et al.                                                                                                                                                                                                                             
